NASDAQ$PGNY
Progyny Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Progyny had a strong fourth quarter, exceeding $100 million in quarterly revenue for the first time and concluding a record year.
Progyny reported a strong fourth quarter with revenue exceeding $100 million for the first time. The company successfully managed the impacts of the COVID-19 pandemic, achieving record levels of revenue, profitability, and operating cash flow.
- Revenue was $100.3 million, a 54% increase compared to Q4 2019.
- Net income was $39.1 million, or $0.39 income per diluted share.
- Adjusted EBITDA was $11.9 million, an increase of $8.0 million from Q4 2019.
- The company had 135 clients as of December 31, 2020, compared to 87 clients as of December 31, 2019.
Headline financials
Revenue & EPS history
Progyny · Revenue · Quarterly
$100M
Revenue by segment
Progyny · $100M total across 2 segments · Q4 2020
- Fertility Benefit Services$74.7M+39.6%74.5%
- Pharmacy Benefit Services$25.6M+120.7%25.5%
Forward guidance
The company is providing financial guidance for the year ended December 31, 2021, and the three-month period ending March 31, 2021.
Tailwinds
- Revenue is projected to be $520.0 million to $540.0 million, reflecting growth of 51% to 57%.
- Net income is projected to be $30.1 million to $37.4 million, or $0.29 to $0.36 per diluted share, on the basis of approximately 103 million assumed weighted-average fully diluted-shares outstanding
- Adjusted EBITDA is projected to be $63.0 million to $68.0 million
- Revenue is projected to be $117.0 million to $122.0 million, reflecting growth of 44% to 51%
- Net income is projected to be $7.5 million to $9.4 million, or $0.07 to $0.09 per diluted share, on the basis of approximately 101 million assumed weighted-average fully diluted-shares outstanding
Headwinds
- Adjusted EBITDA is projected to be $14.0 million to $15.5 million
- The forward-looking statements involve known and unknown risks, uncertainties, and other important factors.
- The actual future results could differ materially from what is expected.
- The company assumes no obligation to update these forward-looking statements publicly, or to update the reasons
- Estimates for stock-based compensation and provision for income taxes include assumptions regarding company share price and the amount and timing of equity exercises, which may differ from actual results.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
-1.1%
Avg return
Earnings day
-0.3%
Avg return
5 days after
-0.2%
Avg return
30 days after
38%
11 / 29 earnings
Positive
+26.4%
Q2 2022
Best reaction
-20.5%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.5% | +25.4% | +38.2% | |
| Q4 2025 | -20.5% | -20.0% | -22.4% | |
| Q3 2025 | +24.3% | +33.6% | +33.4% | |
| Q1 2025 | -9.7% | -6.5% | -7.2% | |
| Q4 2024 | -1.5% | -5.2% | -4.3% | |
| Q3 2024 | -18.5% | -19.3% | -12.9% | |
| Q2 2024 | -17.7% | -14.7% | -6.4% | |
| Q1 2024 | -14.4% | -14.6% | -14.2% | |
| Q4 2023 | -13.1% | -9.7% | -4.3% | |
| Q3 2023 | -4.3% | -2.1% | +17.8% | |
| Q2 2023 | +4.9% | -2.8% | -8.6% | |
| Q1 2023 | +9.3% | +5.9% | +16.8% | |
| Q4 2022 | +22.9% | +18.4% | +7.7% | |
| Q3 2022 | -2.6% | +2.0% | -13.8% | |
| Q2 2022 | +26.4% | +25.5% | +15.4% | |
| Q1 2022 | -7.1% | -15.6% | -23.1% | |
| Q4 2021 | +11.5% | +13.0% | +31.6% | |
| Q3 2021 | +2.5% | +5.8% | -22.2% | |
| Q2 2021 | -12.8% | -17.1% | +4.3% | |
| Q1 2021 | -3.2% | -8.7% | +18.4% | |
| Q4 2020 | -15.5% | -14.9% | -14.4% | |
| Q3 2020 | -0.3% | +7.0% | +38.7% | |
| Q2 2020 | +0.4% | +8.4% | -0.9% | |
| Q1 2019 | -2.4% | +4.8% | -13.7% | |
| Q1 2020 | +21.8% | +18.8% | +2.1% | |
| Q4 2017 | -3.7% | -6.3% | -8.3% | |
| Q4 2019 | -12.2% | -15.5% | -39.0% | |
| Q4 2018 | -0.2% | -5.0% | -7.0% | |
| Q3 2019 | +0.5% | +0.3% | -6.5% | |
| Q2 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro